Teleflex (TFX)
131.91
2.02 (1.56%)
At close: Apr 14, 2025, 3:22 PM
1.56% (1D)
| Bid | 131.63 |
| Market Cap | 5.89B |
| Revenue (ttm) | 3.05B |
| Net Income (ttm) | 69.67M |
| EPS (ttm) | 1.49 |
| PE Ratio (ttm) | 88.53 |
| Forward PE | 11.85 |
| Analyst | Hold |
| Ask | 131.94 |
| Volume | 264,189 |
| Avg. Volume (20D) | 1,165,340 |
| Open | 131.43 |
| Previous Close | 129.89 |
| Day's Range | 129.79 - 132.06 |
| 52-Week Range | 124.66 - 249.91 |
| Beta | 1.19 |
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the wit...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 17, 1980
Employees 14,100
Stock Exchange NYSE
Ticker Symbol TFX
Website https://www.teleflex.com
Analyst Forecast
According to 10 analyst ratings, the average rating for TFX stock is "Hold." The 12-month stock price forecast is $168.5, which is an increase of 27.74% from the latest price.
Stock ForecastsNext Earnings Release
Teleflex is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-21.69%
Teleflex shares are trading lower after the compan...
Unlock content with
Pro Subscription
5 months ago
-14.52%
Teleflex shares are trading lower after the company reported mixed Q3 financial results and cut FY24 revenue growth guidance.
